AFFECTIVE DISORDERS--AN EXPLORATION OF LONG-TERM COURSE
情感障碍——长期历程的探索
基本信息
- 批准号:2250566
- 负责人:
- 金额:$ 12.04万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1993
- 资助国家:美国
- 起止时间:1993-08-01 至 1996-07-31
- 项目状态:已结题
- 来源:
- 关键词:anxiety disorders bipolar depression computer data analysis data collection methodology /evaluation diagnosis quality /standard disease /disorder classification disease /disorder proneness /risk human data longitudinal human study major depression mental disorder diagnosis mood disorders personality tests prognosis psychosis relapse /recurrence schizophrenia social adjustment statistics /biometry
项目摘要
Between 1978 and 1981, the NIMH Collaborative Depression Study conducted
thorough baseline evaluations of 955 probands with major affective
disorder. These subjects have now been followed at semiannual and annual
intervals to ten years with a retention rate of 70.1% of those still
living. The study also evaluated a large sample (N=2,616) of nonclinical
subjects (relatives, controls and spouses) at baseline and again six
years later. A high-intensity substudy has shown that the occurrence and
timing of major depression disorder episodes among the members of this
sample can be validly compared to corresponding measures in the proband
sample. The size, scope, intensity, and duration of these follow-up
efforts have thus generated a unique data set with very broad potential.
Previous CDS publications have been based on shorter follow-up periods
and have emphasized the course of index episodes, the time to subsequent
clinical events, and the long-range prognostic qualities of baseline
measures. The investigators now propose to fully explore the ten-year
follow-up data with a shift in emphasis to the timing and phenomenology
of prospectively observed episodes, to overall trends across repeated
observations, to direct comparisons between probands and nonclinical
subjects, and to the application of new statistical means toward these
ends. The first three of these general aims will circumvent important
selection biases which are inescapable for essentially all other
follow-up studies. The last of these aims will be abetted through an
affiliation with the biostatistics division in the Department of
Preventive Medicine. The investigators intend an emphasis on nosological
questions, a longstanding focus for researchers at the Iowa center.
在1978年至1981年期间,NIMH合作抑郁症研究进行了
对955名主要情感障碍先证者进行了全面的基线评估,
disorder. 这些受试者现在每半年和每年都被跟踪一次。
间隔至10年,留存率为70.1
living. 该研究还评估了一个大样本(N= 2,616)的非临床
受试者(亲属、对照组和配偶)在基线时,
年后 一项高强度的子研究表明,
本研究的成员中抑郁症发作的时间
样本可以有效地与先证者的相应测量进行比较
sample. 这些随访的规模、范围、强度和持续时间
因此,经过努力,产生了一套具有非常广泛潜力的独特数据集。
之前的CDS出版物基于较短的随访期
并强调了指数发作的过程,
临床事件和基线的长期预后质量
措施 调查人员现在建议全面探索十年来
随访数据,重点转向时间和现象学
前瞻性观察到的发作,与重复发作的总体趋势
观察,以直接比较先证者和非临床
主题,并对这些新的统计手段的应用
形接头. 前三个总目标将绕过重要的
选择偏见,这是不可避免的,基本上所有其他
后续研究。 这些目标中的最后一个将通过
与系生物统计部门的联系
预防医学。 研究人员打算强调疾病分类学
问题,这是爱荷华州中心研究人员长期关注的焦点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
William Henry Coryell其他文献
William Henry Coryell的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('William Henry Coryell', 18)}}的其他基金
Cytokines, PUFA Tissue Concentrations and Treatment Selection in Antenatal MMD
产前 MMD 的细胞因子、PUFA 组织浓度和治疗选择
- 批准号:
8265810 - 财政年份:2011
- 资助金额:
$ 12.04万 - 项目类别:
Cytokines, PUFA Tissue Concentrations and Treatment Selection in Antenatal MMD
产前 MMD 的细胞因子、PUFA 组织浓度和治疗选择
- 批准号:
8028436 - 财政年份:2011
- 资助金额:
$ 12.04万 - 项目类别:
Pilot Study of Omega-3 Fatty Acid in Depressive Disorder
Omega-3 脂肪酸治疗抑郁症的初步研究
- 批准号:
7040784 - 财政年份:2004
- 资助金额:
$ 12.04万 - 项目类别:
A COLLABORATIVE GENOMIC STUDY OF BIPOLAR DISORDER
双相情感障碍的合作基因组研究
- 批准号:
2891158 - 财政年份:1998
- 资助金额:
$ 12.04万 - 项目类别:
A Collaborative Genomic Study of Bipolar Disorder
双相情感障碍的合作基因组研究
- 批准号:
6843721 - 财政年份:1998
- 资助金额:
$ 12.04万 - 项目类别:
A Collaborative Genomic Study of Bipolar Disorder
双相情感障碍的合作基因组研究
- 批准号:
7154081 - 财政年份:1998
- 资助金额:
$ 12.04万 - 项目类别:
相似海外基金
Psilocybin Assisted Psychotherapy for Bipolar Depression: An fMRI Emotional-Processing Pilot Study
裸盖菇素辅助双相抑郁心理治疗:功能磁共振成像情绪处理试点研究
- 批准号:
486939 - 财政年份:2023
- 资助金额:
$ 12.04万 - 项目类别:
Miscellaneous Programs
Repeated Ketamine Infusions for Cognitive Impairment in Treatment-Resistant Bipolar Depression
反复输注氯胺酮治疗难治性双相抑郁症的认知障碍
- 批准号:
486443 - 财政年份:2022
- 资助金额:
$ 12.04万 - 项目类别:
Studentship Programs
Neurobiological Effects of Psilocybin in Treatment Resistant Bipolar Depression: An Emotional-Processing fMRI Pilot Study
裸盖菇素对治疗难治性双相抑郁症的神经生物学作用:情绪处理功能磁共振成像初步研究
- 批准号:
486577 - 财政年份:2022
- 资助金额:
$ 12.04万 - 项目类别:
Studentship Programs
Reward and stress: Developing neuroimaging biomarkers for bipolar depression
奖励和压力:开发双相抑郁症的神经影像生物标志物
- 批准号:
2748645 - 财政年份:2022
- 资助金额:
$ 12.04万 - 项目类别:
Studentship
Theta-burst stimulation for bipolar depression: A randomized controlled trial
θ 爆发刺激治疗双相抑郁症:一项随机对照试验
- 批准号:
469571 - 财政年份:2022
- 资助金额:
$ 12.04万 - 项目类别:
Operating Grants
Cannabidiol Adjunctive Therapy for Acute Bipolar Depression: A Randomized Double-Blind Placebo Controlled Trial
大麻二酚辅助治疗急性双相抑郁症:随机双盲安慰剂对照试验
- 批准号:
444068 - 财政年份:2021
- 资助金额:
$ 12.04万 - 项目类别:
Operating Grants
Repeated Ketamine Infusions for Treatment-Resistant Bipolar Depression: A Randomized, Midazolam-Controlled Phase II Clinical Trial
重复氯胺酮输注治疗难治性双相抑郁症:一项随机、咪达唑仑对照的 II 期临床试验
- 批准号:
434675 - 财政年份:2020
- 资助金额:
$ 12.04万 - 项目类别:
Operating Grants
Next Generation Drugs for Bipolar Depression and Maintenance
治疗双相抑郁症和维持治疗的下一代药物
- 批准号:
9555300 - 财政年份:2018
- 资助金额:
$ 12.04万 - 项目类别:
Next generation drugs for bipolar depression and maintenance
用于双相抑郁症和维持治疗的下一代药物
- 批准号:
10080262 - 财政年份:2018
- 资助金额:
$ 12.04万 - 项目类别:
Next generation drugs for bipolar depression and maintenance
用于双相抑郁症和维持治疗的下一代药物
- 批准号:
10588254 - 财政年份:2018
- 资助金额:
$ 12.04万 - 项目类别:














{{item.name}}会员




